(PharmaNewsWire.Com, August 10, 2017 ) Pancreatic cancer (pancreatic ductal adenocarcinoma, PDA) is infamously moving to the top of the list as one of the most lethal cancers. Pancreatic cancer is a disease in which malignant (cancer) cells form in the tissues of the pancreas. Smoking and health history can affect the risk of pancreatic cancer. Signs and symptoms of pancreatic cancer include jaundice, pain, and weight loss. Pancreatic cancer is difficult to detect (find) and diagnose early. Tests that examine the pancreas are used to detect (find), diagnose, and stage pancreatic cancer. Certain factors affect prognosis (chance of recovery) and treatment options.
Pancreatic cancer can be controlled only if it is found before it has spread, when it can be completely removed by surgery. If the cancer has spread, palliative treatment can improve the patient's quality of life by controlling the symptoms and complications of this disease. Previous research had shown that micro RNA (MIR506), a small molecule produced in the human body, had functioned as a tumour suppressor in many human cancers and enhanced chemotherapy’s effectiveness in ovarian cancer. The researchers hypothesized that this molecule was a viable option for further study in pancreatic cancer.
The factors influencing the Global Market for Pancreatic Cancer Therapeutics Market, either positively or negatively are presented in the DROC analysis. Some factors contributing to the growth of the market are large number of unmet needs related to the disease, attracting many multi-national companies to invest in this division, increasing healthcare expenditure, technological developments & drug innovations with regard to the pancreatic cancer and growing concern across the world. However, the factors limiting the growth of the market are difficulty in diagnosis during the early stages, limited treatment options, especially when the disease has spread to other organs or parts of the body, inadequate results after treatment, low success rates in clinical trials for cancer drugs, high cost associated with the treatment, adverse side-effects as well as high toxicity of drugs.
For granular level understanding, the Pancreatic Cancer Therapeutics Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segments.
1) By Type of Treatment • Surgery • Chemotherapy • Radiation Therapy • Others
2) By Cancer Type • Exocrine Pancreas Cancer • Endocrine Pancreas Cancer
3) By End-users • Hospitals • Clinics • Research Institutes • Others
Based on geography, the market is segmented into various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Globally North America is the largest market for pancreatic cancer. The prevalence of pancreatic cancer is more in North American countries with U.S. having the highest number of pancreatic cancer patients in the world. Europe is expected to be the second-largest market for pancreatic cancer. Asia-Pacific is anticipated to be the fastest growing region across the globe.
• North America Pancreatic Cancer Therapeutics Market • Europe Pancreatic Cancer Therapeutics Market • Asia-Pacific Pancreatic Cancer Therapeutics Market • Latin America Pancreatic Cancer Therapeutics Market • Middle East and Africa Pancreatic Cancer Therapeutics Market
Key players in the pancreatic cancer market include Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc. and NewLink Genetics Corp.
The Pancreatic Cancer Therapeutics Market study offers the following deliverables: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming • Segment-level analysis on basis of producttype, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
